How many employees work at PhaseV Trials?

PhaseV Trials, Inc. has approximately 53 total employees worldwide as of March 2026, according to Revelio Labs workforce intelligence data. PhaseV Trials’s total headcount has grown 275.1% from 14 employees in 2023 to 53 in 2026.

Data source: Revelio LabsCoverage: Global workforce, 20232026Published August 2026

Is PhaseV Trials hiring right now?

Yes, PhaseV Trials is actively hiring. PhaseV Trials had 5 active job postings in 2026, a 50.0% increase from 2025 see job openings & hiring trends.

About PhaseV Trials’s Workforce

PhaseV Trials, Inc. is a Pharmaceuticals company that employs 53 people worldwide as of March 2026. It is the 3rd-largest by headcount among its peers. Founded in 2023, the company is headquartered in Cambridge, Massachusetts.

PhaseV Trials's workforce has grown 275.1% from 2023 to 2026, up 12.9% year over year in 2026. Its workforce is concentrated most in Central and Western Asia (62.2%), followed by North America (37.8%).

PhaseV Trials's functional groups are Sales and Marketing (34.9%), Engineering (34.8%), and Finance and Operations (30.3%), with Finance and Operations growing fastest (up 42.4%). The average salary is $129,761, ranging from a median of $184,000 in North America to $104,000 in Central and Western Asia, up 3.1% year over year in 2026.

PhaseV Trials's active job postings rose 50.0% in 2026 to 5, with new postings per month climbing from 0 in 2023 to 4 in 2026.

Sourced from Revelio Labs workforce data.

Headquarters
Cambridge, Massachusetts
Founded
2023
Industry
Pharmaceuticals
Employees
53
YoY
+12.9% (+21)

Unlock hiring rate, attrition rate, and 12 additional workforce metrics for PhaseV Trials. Compare to peers, export the dataset, and access the full quarterly history.

Unlock Metrics

PhaseV Trials Annual Employee Count (2023-2026)

Interactive chart of PhaseV Trials annual worldwide employee count from 2023 to 2026.
  • PhaseV Trials had 53 employees in 2026, a 12.9% increase (+21) from 2025.
  • PhaseV Trials had 48 employees in 2025, a 13.4% increase (+21) from 2024.
  • PhaseV Trials had 27 employees in 2024, a 23.2% increase (+13) from 2023.
  • PhaseV Trials had 14 employees in 2023, a 27.4% increase (+9) from 2022.

PhaseV Trials's total workforce has grown from 14 employees in 2023 to 53 in 2026.

PhaseV Trials, Inc. quarterly employee count

YearQtrEmployeesYoY ChangeYoY %
2026Q153+21+12.9%
2025Q448+21+13.4%
2025Q342+21+12.6%
2025Q236+18+17.6%
2025Q132+16+23.6%
2024Q427+13+23.2%
2024Q321+5+20.3%
2024Q218+4+24.1%
2024Q116+6+29.7%
2023Q414+9+27.4%
2023Q316+13+27.7%
2023Q214+11+19.0%

See PhaseV Trials's complete headcount history, including quarterly breakdowns.

Get the Data

PhaseV Trials Employee Count by Region (2026)

Central and Western Asia accounts for the largest share of PhaseV Trials's global workforce with approximately 62% of total employees, followed by North America.

PhaseV Trials employees by region

RegionEmployees% of Total
Central and Western Asia3262.2%
North America1937.8%

Drill into city-level data, hiring trends by region, and historic geographic shifts.

Unlock Geographic Data

PhaseV Trials Employee Count by Department (2026)

PhaseV Trials's employee groups are Sales and Marketing (34.9%), Engineering (34.8%), and Finance and Operations (30.3%).

PhaseV Trials employees by department

DepartmentEmployees% of Total
Sales and Marketing1834.9%
Engineering1834.8%
Finance and Operations1630.3%

Compare PhaseV Trials's department mix to industry peers.

See Full Data

PhaseV Trials Employee Salary by Region (2026)

PhaseV Trials's average employee salary is $129,761 globally. Employees in North America receive the highest compensation, with median pay approximately 1.4x the global average. Pay is lowest in Central and Western Asia, at a median of $104,000.

PhaseV Trials median employee salary by region (USD)

RegionMedian Salary
North America$184,000
Central and Western Asia$104,000

Unlock salary by role, level, and city — and compare to PhaseV Trials's industry peers.

Unlock Salary Data

PhaseV Trials Job Openings and Hiring Trends (2023-2026)

Interactive chart of PhaseV Trials annual active job postings from 2023 to 2026.
  • PhaseV Trials had 5 active job postings in 2026, a 50.0% increase (-4) from 2025.
  • PhaseV Trials had 9 active job postings in 2025, a 200.0% increase (+9) from 2024.
  • PhaseV Trials had 0 active job postings in 2024, a 200.0% decline (-1) from 2023.
  • PhaseV Trials had 1 active job postings in 2023, a 200.0% increase from 2022.
  • Hiring velocity in 2026: 4 new roles/month, up from 3 in 2025 and 0 in 2024.

PhaseV Trials's hiring is accelerating: active job postings rose 50.0% in 2026 to 5, with new postings per month climbing from 0 in 2023 to 4 in 2026.

Track new postings per month, role-level demand, and hiring velocity vs. peers.

Unlock Hiring Data

Similar Companies

Similar Pharmaceuticals Companies by Employee Count

Frequently Asked Questions About PhaseV Trials

How fast is PhaseV Trials growing?
In 2026, PhaseV Trials's headcount grew 12.9% to 53 employees, up from 32 in 2025.
See the full headcount history
Where are PhaseV Trials employees located?
Most PhaseV Trials employees are based in Central and Western Asia (62.2% of headcount), followed by North America.
Explore where the workforce is based
What is the average salary at PhaseV Trials?
The average employee salary at PhaseV Trials is approximately $129.8k per year.
Analyze the salary distribution
How many new job postings does PhaseV Trials open per year?
In Q1 2026, PhaseV Trials opened 11 new job postings. In 2025, PhaseV Trials opened 32 new job postings — about 3 per month.
Track hiring trends by role
When was PhaseV Trials founded and where is it headquartered?
PhaseV Trials was founded in 2023 and is headquartered in Cambridge, Massachusetts.
Compare PhaseV Trials to industry peers

Speak with a workforce expert about PhaseV Trials.

Book a Demo

See something that doesn't look right? Reach out and our team will review it.